Abstract
Inhibitor of differentiation-4 is highly expressed in glioblastoma multiforme (GBM). We report a novel pro-angiogenic function for inhibitor of differentiation-4 in the growth of glioblastoma xenografts. Tumor-derived cell cultures expressing elevated levels of ID4 produced enlarged xenografts in immunosuppressed mice that were better vascularized than corresponding control tumors and expressed elevated matrix GLA protein (MGP) that mediated enhanced tumor angiogenesis. Inhibition of MGP resulted in smaller and less vascularized xenografts. Our finding shows a novel function for ID4 in tumor angiogenesis, and identifies ID4 and MGP as possible therapeutic targets for GBM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
AndresBarquin PJ, Hernandez MC, Hayes TE, McKay RDG, Israel MA . (1997). Id genes encoding inhibitors of transcription are expressed during in vitro astrocyte differentiation and in cell lines derived from astrocytic tumors. Cancer Res 57: 215–220.
Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P et al. (2001). Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci USA 98: 130–135.
Bellido M, Aventin A, Lasa A, Estivill C, Carnicer MJ, Pons C et al. (2003). Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. Haematologica 88: 994–1001.
Benezra R . (2001). Role of Id proteins in embryonic and tumor angiogenesis. Trends Cardiovasc Med 11: 237–241.
Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H . (1990). The protein Id—a negative regulator of helix-loop-helix DNA-binding proteins. Cell 61: 49–59.
Benezra R, Rafii S, Lyden D . (2001). The Id proteins and angiogenesis. Oncogene 20: 8334–8341.
Bergers G, Benjamin LE . (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401–410.
Bostrom K, Zebboudj AF, Yao YC, Lin TS, Torres A . (2004). Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta 1 activity in endothelial cells. J Biol Chem 279: 52904–52913.
Bouck N, Stellmach V, Hsu SC . (1996). How tumors become angiogenic. Adv Cancer Res 69: 135–174.
Chan ASW, Tsui WY, Chen X, Chu KM, Chan TL, Chan ASY et al. (2003). Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene 22: 6946–6953.
Chen L, Obryan JP, Smith HS, Liu E . (1990). Overexpression of matrix Gla protein messenger-Rna in malignant human breast cells—isolation by differential Cdna hybridization. Oncogene 5: 1391–1395.
de Candia P, Akram M, Benezra R, Brogi E . (2006). Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. Hum Pathol 37: 1032–1041.
Folkman J . (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182–1186.
Folkman J . (2002). Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15–18.
Fontemaggi G, Dell'Orso S, Trisciuoglio D, Shay T, Melucci E, Fazi F et al. (2009). The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nat Struct Mol Biol 16: 1086–1093.
Havrda MC, Harris BT, Mantani A, Ward NM, Paolella BR, Cuzon VC et al. (2008). Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis. J Neurosci 28: 14074–14086.
Holland EC . (2000). Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97: 6242–6244.
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264.
Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, Bennington JL et al. (2003). Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. Cancer Res 63: 7098–7105.
Jeon HM, Jin X, Lee JS, Oh SY, Sohn YW, Park HJ et al. (2008). Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev 22: 2028–2033.
Kargiotis O, Rao JS, Kyritsis AP . (2006). Mechanisms of angiogenesis in gliomas. J Neurooncol 78: 281–293.
Kleihues P, Cavenee WK, International Agency for Research on Cancer., International Society of Neuropathology. (1997). Pathology and Genetics of Tumours of the Nervous System. International Agency for Research on Cancer: Lyon, 255 pp.
Kubota Y, Kleinman HK, Martin GR, Lawley TJ . (1988). Role of laminin and basement-membrane in the morphological-differentiation of human-endothelial cells into capillary-like structures. J Cell Biol 107: 1589–1598.
Lampugnani MG . (1999). Cell migration into a wounded area in vitro. Methods Mol Biol 96: 177–182.
Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET . (1992). Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 52: 534–537.
Liang Y, Bollen AW, Nicholas MK, Gupta N . (2005). Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas. BMC Clin Pathol 5: 6.
Ling MT, Lau TCM, Zhou C, Chua CW, Kwok WK, Wang Q et al. (2005). Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 26: 1668–1676.
Lofstedt T, Jogi A, Sigvardsson M, Gradin K, Poellinger L, Pahlman S et al. (2004). Induction of ID2 expression by hypoxia-inducible factor-1—a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 279: 39223–39231.
Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670–677.
Massari ME, Murre C . (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cel Biol 20: 429–440.
Mikkola HKA, Fujiwara Y, Schlaeger TM, Traver D, Orkin SH . (2003). Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 101: 508–516.
Newman B, Gigout LL, Sudre L, Grant ME, Wallis GA . (2001). Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival. J Cell Biol 154: 659–666.
Ozawa T, Wang JL, Hu LJ, Lamborn KR, Bollen AW, Deen DF . (1998). Characterization of human glioblastoma xenograft growth in athymic mice. in vivo 12: 369–374.
Proudfoot D, Shanahan CM . (2006). Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology 11: 455–461.
Russell RG, Lasorella A, Dettin LE, Iavarone A . (2004). Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Res 64: 7220–7225.
Ruzinova MB, Benezra R . (2003). Id proteins in development, cell cycle and cancer. Trends Cell Biol 13: 410–418.
Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S et al. (2003). Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4: 277–289.
Sakurai D, Tsuchiya N, Yamaguchi A, Okaji Y, Tsuno NH, Kobata T et al. (2004). Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J Immunol 173: 5801–5809.
Shan L, Yu MS, Qiu CP, Snyderwine EG . (2003). Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas. Am J Pathol 163: 2495–2502.
Sikder H, Huso DL, Zhang H, Wang BH, Ryu B, Hwang ST et al. (2003). Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell 4: 291–299.
St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E et al. (2000). Genes expressed in human tumor endothelium. Science 289: 1197–1202.
Umetani N, Mori T, Koyanagi K, Shinozaki M, Kim J, Giuliano AE et al. (2005). Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene 24: 4721–4727.
Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DSB . (2004). Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin Cancer Res 10: 7475–7483.
Vandeputte DAA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, Bosch DA et al. (2002). Expression and distribution of Id helix-loop-helix proteins in human astrocytic tumors. Glia 38: 329–338.
Vermeer C . (2001). Patent Cooperation Treaty. Organization WIP (ed.): Netherlands, pp 1–46.
Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C et al. (2002). Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2: 473–483.
Wu Q, Hoffmann MJ, Hartmann FH, Schulz WA . (2005). Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Mol Cancer 4: 16.
Yu L, Liu CH, Vandeusen J, Becknell B, Dai ZY, Wu YZ et al. (2005). Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genet 37: 265–274.
Yun K, Mantani A, Garel S, Rubenstein J, Israel MA . (2004). Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 131: 5441–5448.
Acknowledgements
Many thanks to Dr Kristina I Boström for lending her expertise, sharing reagents, and fielding generously many questions about MGP. This work was supported by funding from the Theodora B. Betz Foundation (MAI) and the Jordan & Kyra Foundation (MAI).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website )
Rights and permissions
About this article
Cite this article
Kuzontkoski, P., Mulligan-Kehoe, M., Harris, B. et al. Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels. Oncogene 29, 3793–3802 (2010). https://doi.org/10.1038/onc.2010.147
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.147
Keywords
This article is cited by
-
Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin
Breast Cancer Research (2022)
-
RETRACTED ARTICLE: LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p
Cell & Bioscience (2019)
-
Functional Role of Matrix gla Protein in Glioma Cell Migration
Molecular Neurobiology (2018)
-
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function
Oncogene (2015)
-
Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells
BMC Cancer (2013)